Sleep loss as a cardiometabolic risk factor: a narrative review of clinical and public health implications.

A critical consequence of opioid use disorder during pregnancy is the increase in the diagnosis and treatment of neonatal opioid withdrawal syndrome. Multiple studies have shown sex-based differences in various pharmacological characteristics of morphine, including tolerance to analgesia and conditioned analgesia. Female rodents are less responsive to morphine effects compared to males, yet the reasons for this sex difference remain unclear. In this context, we have shown that prepubertal female mice were less likely to exhibit signs of morphine withdrawal syndrome compared to males, consistent with earlier findings. Furthermore, it has been shown that male mice experienced an increase in µ-opioid receptor density during the morphine withdrawal syndrome, while females did not. The emergence of opiate dependence and the manifestation of morphine withdrawal syndrome are a result of homologous regulation processes influencing the endogenous opioid system, along with heterologous regulation that impacts other neurotransmitter systems. Neonatal opioid withdrawal syndrome consists of a range of withdrawal symptoms that infants experience soon after birth because of the sudden halt of drug exposure from mother to child through the placenta. Signs linked to neonatal opioid withdrawal syndrome generally impact the central and autonomic nervous systems, along with the gastrointestinal system. Typical symptoms comprise tremors, irritability, heightened crying, inadequate feeding, sleep issues, elevated muscle tone, fever, unstable temperature, diarrhea, and in severe instances, seizures. It is indeed plausible to conjecture that such behavioral developmental deficits may arise from modifications in the dynamics of mother-infant interactions. In fact, we have recently elucidated that maternal figures experiencing stress during gestation exhibit atypical maternal behaviors, and it has been posited that maternal emotional states during pregnancy significantly impact mother-infant relationships immediately following parturition, throughout the pre weaning phase, thereby influencing the development of the embryonic brain and leading to enduring alterations in the behavioral patterns of the progeny. In murine species, the central nervous system exhibits a pronounced state of immaturity at the time of parturition, necessitating physical activity for its subsequent maturation. The latter catalyzes mechanisms that promote neuroplasticity, including neurogenesis, synaptogenesis, and angiogenesis. Throughout the normative developmental trajectory, the array of general movements exhibited by the limbs undergoes increasing complexity with advancing age, culminating in the acquisition of fluid, precise, and increasingly intricate movements. This augmented variability and sophistication of general movements facilitates the development and refinement of the sensorimotor networks. The attainment of an adequate sensorimotor function is contingent upon the development of the muscular system to adequately support body weight, the execution of efficient motor commands, and the maturation of the vestibular system for maintaining equilibrium, as well as the integration of somatosensory feedback. There exists a body of evidence indicating that these metal oxide nanoparticles may impose deleterious effects within biological systems; consequently, extensive investigations are imperative to assess the safety of employing these innovative pharmacological agents in the management of central nervous system disorders. Nanoparticles (NPs) are defined as particles that possess at least one structural dimension measuring under 100 nm in diameter. Due to their distinct characteristics such as small dimensions and large specific surface area, nanoparticles may exhibit greater toxicity compared to larger particle sizes. Specifically, Zinc oxide nanoparticles (ZONPs) rank among the most frequently used nanomaterials across various industrial sectors, including electronic materials, alloys, wall paints, construction materials, and biological areas like medicine, toothpaste, cosmetics, and sunscreens. Zinc (Zn) is a trace element that can promote growth, heal wounds, regulate immune functions, boost fertility and metabolism, and eliminate free radicals (Kujur et al., 2016). Zinc from organic sources includes zinc lactate, zinc amino acid, and zinc chelate, whereas inorganic sources consist of zinc sulphate and zinc oxide. The effect of ZONP was determined in the lipopolysaccharide- induced depression mice model. ZONP appeared to have beneficial effects in female BALB/c mice with skin infections that were shown by the intradermal injection of ZONP that markedly improved healing from diseases. ZONP (0.5 mg/kg) have an anti-nociception effect in female Wistar rats. The nanoparticles also improved the anti-nociception effect of morphine and naloxone. Based on the reports, there is interaction between ZONP and opioidergic system which ZONP has more efficacy than